drugset / Trial / NCT00370565

Effect on Glycemic Control of Inhaled Insulin Alone or Added to Dual Oral Therapy After Failure of Dual Oral Therapy.

NCT00370565

Phase 3 Completed 345 enrolled Pfizer Nektar Therapeutics · collabSanofi · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

To assess the impact on glucose control by inhaled insulin alone or added to two oral anti-diabetic agents in patients with type 2 diabetes who are not well controlled on 2 oral anti-diabetic agents.

Timeline

Start
1999-06
Primary completion
Completion
2000-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic Inhaled